Psychedelic Commons
ExploreMethodsAbout
Share your data

Andreassen OA

Institute of Clinical Medicine, University of Oslo, Norway.

7 papers · 1 preprint · ORCID

View
ArticleMDMA

Clinical and non-clinical use of MDMA.

Kvam TM, Goksøyr IW, Stewart LH +3

Europe PMC2026
View
PreprintPsychedelics

The non-classic psychedelic muscimol suppresses inflammatory signaling and promotes neuroplasticity in schizophrenia-derived human cortical spheroids and astroglia

Akkouh IA, Osete JR, Ueland T +4

Europe PMC2026
View
ArticleMDMA

MDMA-assisted psychotherapy in major depression: critical considerations for clinical translation: commentary, Kvam et al.

Kvam TM, Goksøyr IW, Rog J +3

Europe PMC2026
View
ArticleMDMA

MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study - CORRIGENDUM.

Kvam TM, Goksøyr IW, Rog J +8

Europe PMC2026
View
ArticleMDMA

MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial.

Kvam TM, Goksøyr IW, Rog J +9

Europe PMC2026
View
ArticleMDMA

MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study.

Kvam TM, Goksøyr IW, Rog J +8

Europe PMC2025
View
ArticleMDMA

Study protocol for "MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study".

Kvam TM, Goksøyr IW, Stewart LH +3

Europe PMC2022
View
ArticlePsilocybin

Psychedelic drugs in the treatment of anxiety, depression and addiction.

Kvam TM, Stewart LH, Andreassen OA

Europe PMC2018
Psychedelic Commons

The open index of psychedelic research.

Explore

All researchDatasetsTrialsShare your data

About

About the hubMethods & accuracyData sources
© 2026 Psychedelic Commons. Metadata aggregated from open sources; all rights remain with the original authors and publishers.